FDA Adverse Event Injury Summary report: N

UNKNOWN_NEUROVASCULAR_PRODUCT

MDR report key: 14379596 · Received May 12, 2022

Report

Report Number
3012931345-2022-00095
Event Type
Injury
Date Received
May 12, 2022
Date of Event
July 20, 2021
Report Date
August 10, 2022
Manufacturer
STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY
Product Code
NRY
PMA / PMN Number
K132641
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE IS NOT AVAILABLE TO THE MANUFACTURER.

Additional Manufacturer Narrative · 0

ALTHOUGH THE DHR COULD NOT BE REVIEWED BECAUSE THE LOT NUMBER REMAINS UNKNOWN, THERE ARE CONTROLS IN THE MANUFACTURING PROCESS TO ENSURE THE PRODUCT MET SPECIFICATIONS UPON RELEASE. NO VISUAL OR FUNCTIONAL INSPECTION WAS PERFORMED DUE TO SUBJECT RETRIEVER DEVICE WAS NOT RETURNED. THE REPORTED EVENT IS COVERED IN THE DEVICE DIRECTIONS FOR USE (DFU). AS WELL, THE RISK OF THE REPORTED EVENT IS DOCUMENTED IN THE RISK DOCUMENTATION AND THERE ARE CURRENT CONTROLS TO MITIGATE THE RISK OF THE AS REPORTED EVENT. IT WAS REPORTED IN A LITERATURE ARTICLE THAT DURING THE CRANIOCERVICAL MECHANICAL THROMBECTOMY PROCEDURE, THE PATIENT EXPERIENCED A DISSECTION OF THE CERVICAL VERTEBRAL ARTERY (V2 SEGMENT). HEPARIN AND ASPIRIN WAS ADMINISTERED TO THE PATIENT AS ADDITIONAL MEDICATION. THE AS REPORTED 'PATIENT VESSEL DISSECTION' IS A KNOWN AND ANTICIPATED COMPLICATION TO THESE TYPES OF PROCEDURES AND PATIENT CONDITION AND IS LISTED AS SUCH IN THE DEVICE DIRECTIONS FOR USE. THEREFORE, A PROBABLE CAUSE OF ANTICIPATED PROCEDURAL COMPLICATION WAS ASSIGNED TO THIS EVENT.

Description of Event or Problem · 0

IT WAS REPORTED IN A LITERATURE ARTICLE SUBMITTED FROM THE DEPARTMENT OF NEURORADIOLOGY, HEIDELBERG UNIVERSITY HOSPITAL GERMANY SUBMITTED AN ARTICLE ABOUT CONCOMITANT ACUTE ISCHEMIC STROKE AND UPPER EXTREMITY ARTERIAL OCCLUSION: FEASIBILITY OF MECHANICAL THROMBECTOMY OF THE UPPER LIMB USING NEURO INTERVENTIONAL DEVICES AND TECHNIQUES IN GERMANY, PUBLISHED IN 20 JULY 2021. DURING THE CRANIOCERVICAL OCCLUSION CASE THE PATIENT PRESENTED WITH HIGH GRADE STENOSIS IN THE RIGHT - SIDED OCCLUSION OF THE COMMON CAROTID ARTERY IT WAS TREATED WITH THE PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) AND STENTING OF A HIGH-GRADE STENOSIS. DURING CRANIOCERVICAL MECHANICAL THROMBECTOMY PROCEDURE A DISSECTION OF THE CERVICAL VERTEBRAL ARTERY (V2-SEGMENT), WHICH WAS TREATED PHARMACOLOGICALLY BY THE ADMINISTRATION OF HEPARIN AND ASPIRIN. DUE TO THE ONLY MINOR HEMODYNAMIC EFFECTS AND GOOD FLOW VIA THE CONTRALATERAL VERTEBRAL ARTERY, NO INTERVENTIONAL TREATMENT WAS NECESSARY. NO PATIENT CLINICAL CONSEQUENCES WERE REPORTED. NO OTHER INFORMATION IS AVAILABLE ABOUT THIS EVENT.

Description of Event or Problem · 0

IT WAS REPORTED IN A LITERATURE ARTICLE SUBMITTED FROM THE THE DEPARTMENT OF NEURORADIOLOGY, HEIDELBERG UNIVERSITY HOSPITAL GERMANY SUBMITTED AN ARTICLE ABOUT CONCOMITANT ACUTE ISCHEMIC STROKE AND UPPER EXTREMITY ARTERIAL OCCLUSION: FEASIBILITY OF MECHANICAL THROMBECTOMY OF THE UPPER LIMB USING NEUROINTERVENTIONAL DEVICES AND TECHNIQUES IN GERMANY, PUBLISHED IN 20 JULY 2021. DURING THE CRANIOCERVICAL OCCLUSION CASE THE PATIENT PRESENTED WITH HIGH GRADE STENOSIS IN THE RIGHT - SIDED OCCLUSION OF THE COMMON CAROTID ARTERY IT WAS TREATED WITH THE PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) AND STENTING OF A HIGH-GRADE STENOSIS. DURING CRANIOCERVICAL MECHANICAL THROMBECTOMY PROCEDURE A DISSECTION OF THE CERVICAL VERTEBRAL ARTERY (V2-SEGMENT), WHICH WAS TREATED PHARMACOLOGICALLY BY THE ADMINISTRATION OF HEPARIN AND ASPIRIN. DUE TO THE ONLY MINOR HEMODYNAMIC EFFECTS AND GOOD FLOW VIA THE CONTRALATERAL VERTEBRAL ARTERY, NO INTERVENTIONAL TREATMENT WAS NECESSARY. NO PATIENT CLINICAL CONSEQUENCES WERE REPORTED. NO OTHER INFORMATION IS AVAILABLE ABOUT THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
411062 UNKNOWN_NEUROVASCULAR_PRODUCT CATHETER, THROMBUS RETRIEVER NRY STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other